Hadhami Ben Turkia

Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1

Pramod K. Mistry, Elena Lukina, Hadhami Ben Turkia et al. · JAMA · 2015 · 152 citations · Full text

Outcomes after 18 months of eliglustat therapy in treatment‐naïve adults with <scp>G</scp>aucher disease type 1: The phase 3 ENGAGE trial

Pramod K. Mistry, Elena Lukina, Hadhami Ben Turkia et al. · American Journal of Hematology · 2017 · 96 citations · Full text

Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double‐blind, multinational, Phase 3 study

Derlis Gonzalez, Hadhami Ben Turkia, Elena Lukina et al. · American Journal of Hematology · 2012 · 84 citations · Full text

Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease

Hadhami Ben Turkia, Derlis Gonzalez, Norman W. Barton et al. · American Journal of Hematology · 2012 · 70 citations · Full text

Immunohematology, Gaucher Disease, Enzyme Replacement Therapy +8

Clinical outcomes after 4.5 years of eliglustat therapy for <scp>Gaucher</scp> disease type 1: Phase 3 <scp>ENGAGE</scp> trial final results

Pramod K. Mistry, Elena Lukina, Hadhami Ben Turkia et al. · American Journal of Hematology · 2021 · 40 citations · Full text